isabelobrien, Author at European Medical Journal - Page 44 of 66

Tipping the scales of KOL success

How can pharma maximise the impact of key opinion leaders in the ever-evolving digital world?

Attracting diverse talent into STEM

This infographic explores how the pharmaceutical industry is attracting and supporting the future STEM workforce with DE&I initiatives.

Challenging the postcode health lottery

A postcode can determine health outcomes more than genetics. How can pharma help to solve the postcode lottery?

The price is wrong

The pandemic has exacerbated already troubling trends in the market access but has also created an opportunity for change in how drugs are priced and procured.

Examining pharma's role in protecting the planet

Pharma is making great strides in tackling climate change, but more needs to be done to meet net zero targets.

Davidek Herron on the future of pharma

In his second column, Davidek Herron, Global Head of Digital, Roche, considers this year’s successes and challenges and looks ahead to 2023.

Is the pharma rep at death's door?

While technology advances and mindsets shift, will there be space and demand for the role of the pharma sales reps in future?

Pharma in Japan

The Japanese pharma industry has many intricacies, so how can companies navigate the ups and downs?

Creating winning pharma communications

Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax, discusses her passion for engaging the world in the wonder of science.

Pharma's sustainability agenda centre stage in new ABPI report

Global action is required to ensure pharma’s commitments to reach Net Zero are realised, according to a new ABPI report.